about
Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians.Fermentation of Green Tea with 2% Aquilariae lignum Increases the Anti-Diabetic Activity of Green Tea Aqueous Extracts in the High Fat-Fed Mouse.Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.Anti-obesity effects of yellow catfish protein hydrolysate on mice fed a 45% kcal high-fat diet.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid lowering therapy in type 2 diabetes.
@en
Lipid lowering therapy in type 2 diabetes.
@nl
type
label
Lipid lowering therapy in type 2 diabetes.
@en
Lipid lowering therapy in type 2 diabetes.
@nl
prefLabel
Lipid lowering therapy in type 2 diabetes.
@en
Lipid lowering therapy in type 2 diabetes.
@nl
P2860
P1476
Lipid lowering therapy in type 2 diabetes.
@en
P2093
Bernhard Föger
P2860
P2888
P304
P356
10.1007/S10354-011-0908-4
P577
2011-06-01T00:00:00Z